永安药业(002365.SZ)：上半年净利润1249.57万元 同比下降76.19%

Group 1 - The core viewpoint of the article highlights that Yong'an Pharmaceutical (002365.SZ) reported a significant decline in both revenue and net profit for the first half of 2025 [1] Group 2 - The company achieved an operating income of 367 million yuan, representing a year-on-year decrease of 13.72% [1] - The net profit attributable to shareholders of the listed company was 12.4957 million yuan, down 76.19% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.2853 million yuan, a decrease of 93.65% year-on-year [1] - The basic earnings per share were 0.0432 yuan [1]